Financials

News Discussions Technicals Seasonals

6885 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

BRIM Biotechnology, Inc. engages in the research and development of treatment drugs. It offers medicines for dry eye syndrome, corneal damage repair, neurotrophic keratitis, and osteoarthritis. The company was founded by Hai Shan Jian and Wen Chi Lee on July 31, 2013 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6885 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company